Ftse Mib
33.414,56
0,46%
DAX
19.626,45
1,05%
S&P 500
6.032,38
0,56%
NASDAQ
19.218,17
0,83%
Bitcoin
96.208,60
-0,24%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Revvity Inc (RVTY) Revvity Inc (RVTY) Notizie

Revvity Inc

RVTY
116,14
-0,09 (-0,08%)
29 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/11/202414:00BWRevvity Broadens Relationship with Genomics England to..
19/11/202414:00BWRevvity to Present at 7th Annual Evercore ISI HealthCONx..
18/11/202414:00BWRevvity to Host Investor Day and Updates Organizational..
14/11/202422:30EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202419:28EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202418:54EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
06/11/202422:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/11/202412:11EDGAR2Form 8-K - Current report
04/11/202412:00BWRevvity Announces Financial Results for the Third Quarter of..
24/10/202422:05BWRevvity Board Declares Quarterly Dividend
22/10/202415:00BWRevvity Introduces Transcribe AI: Revolutionizing Data Entry..
22/10/202414:00BWRevvity Highlights its Strong Progress on Sustainability and..
10/10/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/10/202422:21EDGAR2Form 144 - Report of proposed sale of securities
09/10/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/10/202422:42EDGAR2Form 144 - Report of proposed sale of securities
07/10/202423:21EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
07/10/202414:00BWRevvity To Hold Earnings Call on Monday, November 4, 2024
02/10/202414:00BWRevvity's EUROIMMUN Launches Solution for Specific Typing of..
17/9/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202414:00BWRevvity to Present at Upcoming Investor Conferences
16/8/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202415:53EDGAR2Form 144 - Report of proposed sale of securities
08/8/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202422:59EDGAR2Form 144 - Report of proposed sale of securities
06/8/202422:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/7/202412:06EDGAR2Form 8-K - Current report
29/7/202412:00BWRevvity Announces Financial Results for the Second Quarter..
25/7/202422:15BWRevvity Board Declares Quarterly Dividend
09/7/202414:00BWRevvity To Hold Earnings Call on Monday, July 29, 2024
20/6/202414:00GLOBEBionano Announces Software Marketing Agreement with Revvity..
18/6/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202416:16EDGAR2Form 144 - Report of proposed sale of securities
31/5/202414:00EDGAR2Form SD - Specialized disclosure report
28/5/202414:00BWRevvity to Present at Goldman Sachs Global Healthcare..
15/5/202421:54EDGAR2Form 144 - Report of proposed sale of securities
07/5/202420:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/4/202412:00BWRevvity Announces Financial Results for the First Quarter of..
25/4/202422:15BWRevvity Board Declares Quarterly Dividend
25/4/202414:00BWRevvity to Present at BofA Securities 2024 Health Care..
24/4/202412:00BWRevvity Unveils a New Era of Automated Tuberculosis Testing
15/4/202412:00BWRevvity Signals Software’s New Synergy Solution Redefines..
04/4/202414:00BWRevvity To Hold Earnings Call on Monday, April 29, 2024
02/4/202412:00BWPreliminary Injunction Granted to Enforce Revvity’s Rights..
20/3/202422:00BWRevvity Files Complaint and Seeks Injunctive Relief Against..
18/3/202411:00BWRevvity Signals Software Introduces Signals ChemDraw..
29/2/202422:11EDGAR2Form 144 - Report of proposed sale of securities
29/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202420:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
Apertura: 116,06 Min: 115,72 Max: 116,92
Chiusura: 116,23

La tua Cronologia

NYSE
RVTY
Revvity
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network